Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Limited has submitted a routine monthly compliance report to BSE regarding the re-lodgement of physical share transfer requests, as required under SEBI Circular dated July 2, 2025. The report, prepared by the company's Registrar and Share Transfer Agent (Aarthi Consultants Limited), covers the month ended November 30, 2025. All key metrics are reported as NIL — no new requests were received, no requests were processed, approved, or rejected during the month. The filing is purely informational and procedural in nature, submitted by the Company Secretary for the company's records.
No material impact on shareholders or the stock. This is a standard compliance disclosure confirming zero activity in physical share transfer re-lodgements for the month, indicating either low investor engagement with physical shares or that the special SEBI window saw no usage for this company.